A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2004
12/02/2004	US20040242497 Ammonium glycyrrhyzinate masks the bitter taste of paroxetine hydrochloride and has a distinctive licorice flavor; dispersable powders or tablets; antidepressants; Parkinson's disease
12/02/2004	US20040242493 Neurotensin active 2,3,diaryl-pyrazolidine derivatives
12/02/2004	US20040242480 Method for treating coumarin-induced hemorrhage
12/02/2004	US20040242476 Peptide and analogs thereof having an amino acid sequence corresponding to the second extracellular domain of a mammalian occludin; may be administered orally or parenterally
12/02/2004	US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist
12/02/2004	US20040242457 Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent
12/02/2004	US20040242455 which exerts potent and selective activated blood coagulation factor X inhibitory activity and is useful for prevention or treatment of disease associated therewith
12/02/2004	US20040241837 Methods for forming normal regenerated tissues, the normal regenerated tissues, and method of calibrating sensitivity and so on
12/02/2004	US20040241818 Assay
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241792 Substrates and assays for beta-secretase
12/02/2004	US20040241757 Membrane protein for use in identifying modulators for treatment and prevention neuronal trauma and disorders
12/02/2004	US20040241310 Method of producing antibodies ex-vivo
12/02/2004	US20040241248 Crosslinking the carboxylic acid groups in a glycosaiminoglycan with a primary amine in a lipid to form particles that can be used to encapsulate various drugs, especially chemotherapeutic agents
12/02/2004	US20040241228 Spirolaxine acts as active principle in association with all-trans retinoic acid for treatment of those pathologies responding to activation of PPAR gamma receptor, such as acute malignant haemopathies. and Type 2 insulin-resistant diabetes
12/02/2004	US20040241226 Administering a tyrosine kinase inhibitor, more particularly a non toxic, potent and selective c-kit inhibitor, wherein said inhibitor is unable to promote death of IL-3 dependent cells cultured to presence of IL-3
12/02/2004	US20040241171 Leukocyte inactivation module
12/02/2004	US20040241166 Use of inhibitors of ikk-beta and method for discovery of said inhibitors
12/02/2004	US20040241156 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder
12/02/2004	US20040241147 antigen presenting cells which express major histocomatibility complexes, used as vaccines
12/02/2004	US20040241140 Expression vectors able to elicit improved immune response and methods of using same
12/02/2004	US20040238781 Using genistein; preadministering before exposure to radiation; prevent tissue damage
12/02/2004	US20040237716 Titanium-group metal containing high-performance water, and its producing method and apparatus
12/02/2004	CA2526374A1 2-aminoquinoline derivatives
12/02/2004	CA2525696A1 Control of function of intracellular ca ion
12/01/2004	EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues
12/01/2004	EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues
12/01/2004	EP1481977A1 Nitrogen-containing heterocyclic compound
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481689A1 Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
12/01/2004	EP1481679A1 Antidepressant
12/01/2004	EP1481678A1 Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with angiogenesis inhibitor
12/01/2004	EP1481675A1 Body temperature elevating agents
12/01/2004	EP1481673A1 Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist
12/01/2004	EP1481671A1 Compositions and foods for improving lipid metabolism
12/01/2004	EP1481668A1 Use of anti-glaucoma drugs to treat visual field defects associated with the use of a GABAergic agent
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481251A2 Estrogen receptor interaction with a transcription factor
12/01/2004	EP1481250A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
12/01/2004	EP1481095A2 Method and nucleic acids for the analysis of colon cell proliferative disorders
12/01/2004	EP1481093A2 MODULATION OF TYPE II&bgr; PHOSPHOINOSITIDE PHOSPHATE KINASE
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1481000A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
12/01/2004	EP1480986A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/01/2004	EP1480984A2 Condensed camptothecins as antitumor agents
12/01/2004	EP1480983A1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
12/01/2004	EP1480980A2 Syntheses of quinazolinones
12/01/2004	EP1480977A2 Substituted aryl compounds for treatment of disease
12/01/2004	EP1480976A1 Thiazole derivatives as npy receptor antagonists
12/01/2004	EP1480975A2 Chemical compounds
12/01/2004	EP1480974A1 Heterocyclylmethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004	EP1480971A1 Isoquinoline derivatives
12/01/2004	EP1480964A1 Inhibiteurs de l'angiogenese
12/01/2004	EP1480963A1 Method for producing 3-amidinophenylalanine derivatives
12/01/2004	EP1480962A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
12/01/2004	EP1480961A1 Glutaminyl based dpiv inhibitors
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480957A1 Hppars activators
12/01/2004	EP1480951A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
12/01/2004	EP1480948A1 Semicarbazide derivatives and their use as antithrombotics
12/01/2004	EP1480946A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity
12/01/2004	EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors
12/01/2004	EP1480736A2 Microcapsules having high carotenoid content
12/01/2004	EP1480688A1 N-(5- 4-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine coated stents
12/01/2004	EP1480679A1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
12/01/2004	EP1480676A1 Combinations of (a) an atp-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents
12/01/2004	EP1480668A1 Compositions and methods for promoting lipid mobilization, glycogen mobilization,or both, in humans
12/01/2004	EP1480656A1 Hyaluronic acid mediated adenoviral transduction
12/01/2004	EP1480650A1 Novel crystalline forms of the anti-cancer compound zd1839
12/01/2004	EP1480649A2 Stable pharmaceutical compositions
12/01/2004	EP1480648A1 Anti-viral compounds
12/01/2004	EP1480647A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
12/01/2004	EP1480644A2 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
12/01/2004	EP1480642A1 Peroxisome proliferator activated receptor modulators
12/01/2004	EP1480640A1 Peroxisome proliferator activated receptor modulators
12/01/2004	EP1480637A1 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
12/01/2004	EP1480634A2 Treating benign prostate hyperplasia with sarms
12/01/2004	EP1480630A1 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa
12/01/2004	EP1480627A1 Methods of reducing angiogenesis
12/01/2004	EP1480624A2 Pharmaceutical tablet
12/01/2004	EP1480623A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
12/01/2004	EP1480621A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
12/01/2004	EP1480620A2 (ester)-lysolecithins in liposomes
12/01/2004	EP1480615A1 Formoterol superfine formulation
12/01/2004	EP1480613A1 Jojoba product for reducing weight, blood lipid levels and for the prevention and treatment of cancer
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480521A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
12/01/2004	EP1480517A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
12/01/2004	EP1480514A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
12/01/2004	EP1399448B1 Imidazo 1,5-a] pyrimido 5,4-d] benzazepine derivatives as gaba a receptor modulators
12/01/2004	EP1368352B1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
12/01/2004	EP1358180B1 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/01/2004	EP1280522B1 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
12/01/2004	EP1212428B1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression

1 ... 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 ... 1564